Company: HVIIR
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010497
Chunk: 116

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 4
Chunk 116
---
 or lead to material adverse effects on a post-business combination
company. Among other things, historical financial performance of companies affected by trade policies and/or tariffs may not provide useful
guidance as to the future performance of such companies, because future financial performance of those companies may be materially affected
by new U.S. tariffs or foreign retaliatory tariffs, or other changes to trade policies. The business prospects of a particular target
for a business combination could change even after HVII enters into a business combination agreement, as a result of tariffs or the threat
of tariffs that may have a material impact on that target’s business, and it may be costly or impractical for HVII to terminate
that business combination agreement. These factors could affect HVII’s selection of a business combination target.

HVII may not be able to adequately
address the risks presented by these tariffs or other potential trade policy changes. As a result, HVII may deem it costly, impractical
or risky to complete a business combination with a particular target or with a target in a particular industry or from a particular country.
Consequently, the pool of potential target companies may be reduced, which could impair HVII’s ability to identify a suitable target
and to complete a business combination. If HVII completes a business combination with such a target, the post-business combination company’s
operations and financial results could be adversely affected as a result of tariffs or changes to trade policies, which may cause the
market value of the securities of the post-business combination company to decline.

25

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On October 8, 2024, HVII’s
sponsor purchased an aggregate of 5,750,000 Class B ordinary shares for an aggregate purchase price of $25,000, or approximately $0.004
per share. On January 10, 2025, HVII issued to HVII’s sponsor an additional 958,333 Class B ordinary shares for no additional consideration,
resulting in HVII’s sponsor holding a total of 6,708,333 Class B ordinary shares. The number of Class B ordinary shares issued was
determined based on the expectation that the Class B ordinary shares would represent 25% of the outstanding ordinary shares of HVII upon
completion of HVII’s initial public offering. In December 2024, HVII’s sponsor transferred 250,000 Class B ordinary shares
to Nicholas Geeza, HVII’s